A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome

A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating disease usually presenting after infection. Emerging evidence supports that energy metabolism is affected in ME/CFS, but a unifying metabolic phenotype has not been firmly established. We performed global metabolomics, lip...

Полное описание

Библиографические подробности
Главные авторы:	Fredrik Hoel, August Hoel, Ina K.N. Pettersen, Ingrid G. Rekeland, Kristin Risa, Kine Alme, Kari Sørland, Alexander Fosså, Katarina Lien, Ingrid Herder, Hanne L. Thürmer, Merete E. Gotaas, Christoph Schäfer, Rolf K. Berge, Kristian Sommerfelt, Hans-Peter Marti, Olav Dahl, Olav Mella, Øystein Fluge, Karl J. Tronstad
Формат:	Статья
Язык:	English
Опубликовано:	American Society for Clinical investigation 2021-08-01
Серии:	JCI Insight
Предметы:	Immunology Metabolism
Online-ссылка:	https://doi.org/10.1172/jci.insight.149217

Схожие документы

Activity monitoring and patient-reported outcome measures in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients.
по: Ingrid G Rekeland, и др.
Опубликовано: (2022-01-01)

Activity monitoring and patient-reported outcome measures in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients
по: Ingrid G. Rekeland, и др.
Опубликовано: (2022-01-01)

Six-year follow-up of participants in two clinical trials of rituximab or cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
по: Ingrid G Rekeland, и др.
Опубликовано: (2024-01-01)

Reduced Endothelial Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome–Results From Open-Label Cyclophosphamide Intervention Study
по: Kari Sørland, и др.
Опубликовано: (2021-03-01)

B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment.
по: Øystein Fluge, и др.
Опубликовано: (2015-01-01)

Serum BAFF and APRIL Levels, T-Lymphocyte Subsets, and Immunoglobulins after B-Cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Myalgic Encephalopathy/Chronic Fatigue Syndrome.
по: Sigrid Lunde, и др.
Опубликовано: (2016-01-01)

No replication of previously reported association with genetic variants in the T cell receptor alpha (TRA) locus for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
по: Marthe Ueland, и др.
Опубликовано: (2022-07-01)

Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series
по: Mella Olav, и др.
Опубликовано: (2009-07-01)

Medical School Education on Myalgic Encephalomyelitis
по: Nina Muirhead, и др.
Опубликовано: (2021-05-01)

Myalgic encephalomyelitis - enigma at the medicine’s crossroads
по: Pavlović Dragan M., и др.
Опубликовано: (2021-01-01)

Myalgic Encephalomyelitis (ME) or What? An Operational Definition
по: Frank Twisk
Опубликовано: (2018-09-01)

Myalgic Encephalomyelitis or What? The International Consensus Criteria
по: Frank Twisk
Опубликовано: (2018-12-01)

The viral origin of myalgic encephalomyelitis/chronic fatigue syndrome.
по: Maureen R Hanson
Опубликовано: (2023-08-01)

‘The Lightning Process’ and chronic fatigue syndrome/myalgic encephalomyelitis
по: Rosamund Vallings
Опубликовано: (2022-01-01)

Restricted Spatial Windows of Visibility in Myalgic Encephalomyelitis (ME)
по: Nadia S. Ahmed, и др.
Опубликовано: (2018-01-01)

Visual Aspects of Reading Performance in Myalgic Encephalomyelitis (ME)
по: Rachel L. Wilson, и др.
Опубликовано: (2018-08-01)

Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study.
по: Øystein Fluge, и др.
Опубликовано: (2011-01-01)

Missing the meaning and provoking resistance; a case of myalgic encephalomyelitis.
по: Butler, C, и др.
Опубликовано: (1996)

Peripheral endothelial dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome
по: Nadja Scherbakov, и др.
Опубликовано: (2020-06-01)

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Human Herpesviruses Are Back!
по: Maria Eugenia Ariza
Опубликовано: (2021-01-01)

Eukaryotes in the gut microbiota in myalgic encephalomyelitis/chronic fatigue syndrome
по: Alexandra H. Mandarano, и др.
Опубликовано: (2018-01-01)

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Neurological Entity?
по: Iñigo Murga Gandasegui, и др.
Опубликовано: (2021-09-01)

Biomarkers in the diagnostic algorithm of myalgic encephalomyelitis/chronic fatigue syndrome
по: Sabine Gravelsina, и др.
Опубликовано: (2022-10-01)

Pathological Mechanisms Underlying Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
по: Daniel Missailidis, и др.
Опубликовано: (2019-07-01)

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Comprehensive Review
по: Mateo Cortes Rivera, и др.
Опубликовано: (2019-08-01)

Onset Patterns and Course of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
по: Lily Chu, и др.
Опубликовано: (2019-02-01)

Will COVID-19 Lead to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?
по: Anthony L. Komaroff, и др.
Опубликовано: (2021-01-01)

An Audit of UK Hospital Doctors’ Knowledge and Experience of Myalgic Encephalomyelitis
по: Keng Ngee Hng, и др.
Опубликовано: (2021-08-01)

Evaluation of four clinical laboratory parameters for the diagnosis of myalgic encephalomyelitis
по: Kenny L. De Meirleir, и др.
Опубликовано: (2018-11-01)

Evidence-based care for people with chronic fatigue syndrome and myalgic encephalomyelitis
по: Sharpe, M, и др.
Опубликовано: (2021)

Evidence-based care for people with chronic fatigue syndrome and myalgic encephalomyelitis
по: White, PD, и др.
Опубликовано: (2022)

Association between chronic fatigue syndrome/myalgic encephalomyelitis and cardiovascular disease
по: Mawulorm K. I. Denu, и др.
Опубликовано: (2025-01-01)

Tetrahydrobiopterin in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Friend or Foe?
по: A. F. M. Towheedur Rahman, и др.
Опубликовано: (2025-01-01)

Cytokines in the Cerebrospinal Fluids of Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis
по: D. Peterson, и др.
Опубликовано: (2015-01-01)

Development of an expert system for the classification of myalgic encephalomyelitis/chronic fatigue syndrome
по: Fatma Hilal Yagin, и др.
Опубликовано: (2024-03-01)

Deep phenotyping of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome
по: Brian Walitt, и др.
Опубликовано: (2024-02-01)

Comparison of T-cell receptor diversity of people with myalgic encephalomyelitis versus controls
по: Joshua J Dibble, и др.
Опубликовано: (2024-01-01)

Angina Simultaneously Diagnosed with the Recurrence of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
по: Koki Li, и др.
Опубликовано: (2021-03-01)

Factors Influencing the Prognosis of Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
по: Alaa Ghali, и др.
Опубликовано: (2022-10-01)

Genome-epigenome interactions associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
по: Santiago Herrera, и др.
Опубликовано: (2018-12-01)